Myomo to Present at the Summer Solstice – Best Ideas From the Buy Side Conference
BOSTON, Mass. (May 27, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that CEO Paul R. Gudonis and CFO David Henry will present at the Summer Solstice – Best Ideas From the […]
Myomo Reports First Quarter 2021 Financial Results
Revenue of $2.3 million up 132% over prior year Gross margin of 73% up 500 basis points over prior year Q1 cash used in operations decreased 14% to $2.1 million Conference call begins at 4:30 p.m. Eastern time today BOSTON, Mass. (May 5, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a […]
Myomo to Report First Quarter 2021 Financial Results on May 5, 2021
BOSTON, Mass., (April 27, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months ended March 31, 2021 on May 5, 2021 after the […]
Myomo Participates in Ground-breaking Brain-computer Interface Trial
Thomas Jefferson University Successfully Controls MyoPro Directly from Brain Implant BOSTON, Mass. (April 1, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Thomas Jefferson University of Philadelphia has successfully completed the […]
Myomo Reports Fourth Quarter and Full Year 2020 Financial Results
Record Q4 2020 revenue of $3.8 million up 149% over prior year Full year 2020 revenue of $7.6 million up 98% vs. 2019 Q4 gross margin of 73% up 100 basis points over prior year Q4 cash used in operations of $1.2 million lowest since June 2017 IPO Conference call begins at 4:30 p.m. Eastern […]
Myomo to Participate in Three Investment Conferences During the Month of March
BOSTON, Mass., March 4, 2021– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul R. Gudonis, Myomo’s CEO, and David Henry, Myomo’s CFO will participate in three virtual investment conferences during the month […]
Myomo to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021
BOSTON, Mass., (March 4, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months and year ended December 31, 2020 on March 10, 2021 […]
Germany’s Largest Statutory Health Insurance Company Approves MyoPro
Follows approval by several other major German providers BOSTON, Mass. (February 16, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced Techniker Krankenkasse (TK), Germany’s largest Statutory Health Insurance (SHI) company, now approves reimbursement […]
Myomo to Present at the Winter Wonderland – Best Ideas from the Buy-side Conference
CAMBRIDGE, Mass. (February 12, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will present at the Winter Wonderland – Best Ideas from the Buy-side Conference. The conference is being held […]
Myomo® Forms Joint Venture to Manufacture and Sell the Company’s Products in China
Joint Venture intends to enter into technology agreement with upfront license fee and minimum purchase requirements CAMBRIDGE, Mass. (January 26, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces the signing of a […]